Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates

分组1 - Boston Scientific reported quarterly earnings of $0.62 per share, exceeding the Zacks Consensus Estimate of $0.58 per share, and up from $0.53 per share a year ago, representing an earnings surprise of 6.90% [1] - The company achieved revenues of $4.12 billion for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 2.51%, and an increase from $3.6 billion year-over-year [1] - Boston Scientific has consistently surpassed consensus EPS and revenue estimates over the last four quarters [1] 分组2 - The stock has gained approximately 35.9% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [2] - The current consensus EPS estimate for the upcoming quarter is $0.57 on revenues of $3.95 billion, and for the current fiscal year, it is $2.32 on revenues of $15.99 billion [4] - The Medical - Products industry is currently ranked in the top 41% of over 250 Zacks industries, indicating a favorable outlook for stocks within this sector [5]